|
1
|
Wu Z and McGoogan JM: Characteristics of
and important lessons from the coronavirus disease 2019 (COVID-19)
outbreak in China: Summary of a report of 72 314 cases from the
Chinese Center for Disease Control and Prevention. JAMA.
323:1239–1242. 2020. View Article : Google Scholar
|
|
2
|
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H,
Wu Y, Zhang L, Yu Z, Fang M, et al: Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China:
A single-centered, retrospective, observational study. Lancet
Respir Med. 8:475–481. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li JY, You Z, Wang Q, Zhou ZJ, Qiu Y, Luo
R and Ge XY: The epidemic of 2019-novel-coronavirus (2019-nCoV)
pneumonia and insights for emerging infectious diseases in the
future. Microbes Infect. 22:80–85. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S,
Huang H, Li Zhang, L Zhou X, Du C, et al: Risk factors associated
with acute respiratory distress syndrome and death in patients with
coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern
Med. Mar 13–2020.2020 (Epub ahead of print). View Article : Google Scholar :
|
|
5
|
Grasselli G, Pesenti A and Cecconi M:
Critical care utilization for the COVID-19 outbreak in Lombardy,
Italy: Early experience and forecast during an emergency response.
JAMA. 323:15452020. View Article : Google Scholar
|
|
6
|
Goumenou M, Sarigiannis D, Tsatsakis A,
Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii
V, Spandidos DA, et al: COVID-19 in Northern Italy: An integrative
overview of factors possibly influencing the sharp increase of the
outbreak (Review). Mol Med Rep. 22:20–32. 2020.PubMed/NCBI
|
|
7
|
Petrakis D, Margină D, Tsarouhas K, Tekos
F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A:
Obesity - a risk factor for increased COVID-19 prevalence, severity
and lethality (Review). Mol Med Rep. 22:9–19. 2020.PubMed/NCBI
|
|
8
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI
|
|
9
|
Kluge S, Janssens U, Welte T,
Weber-Carstens S, Marx G and Karagiannidis C: German
recommendations for critically ill patients with COVID-19. Med Klin
Intensivmed Notfmed. Apr 14–2020.Epub ahead of print. View Article : Google Scholar
|
|
10
|
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim
R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans
L, et al: Covid-19 in critically ill patients in the Seattle region
- case series. N Engl J Med. 382:2012–2022. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Farsalinos K, Niaura R, Le Houezec J,
Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A and Poulas K:
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of
the nicotinic cholinergic system. Toxicol Rep. 7:658–663. 2020.
View Article : Google Scholar :
|
|
12
|
Calfee CS, Delucchi K, Parsons PE,
Thompson BT and Ware LB: Subphenotypes in acute respiratory
distress syndrome: Latent class analysis of data from two
randomised controlled trials. Lancet Respir Med. 2:611–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilson JG and Calfee CS: ARDS
subphenotypes: Understanding a heterogeneous syndrome. Crit Care.
24:1022020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Famous KR, Delucchi K, Ware LB, Kangelaris
KN, Liu KD and Thompson BT: Acute respiratory distress syndrome
subphenotypes respond differently to randomized fluid management
strategy. Am J Respir Crit Care Med. 195:331–338. 2017. View Article : Google Scholar :
|
|
15
|
Calfee CS, Delucchi KL, Sinha P, Matthay
MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O′Kane CM,
McAuley DF, et al Irish Critical Care Trials Group: Acute
respiratory distress syndrome subphenotypes and differential
response to simvastatin: Secondary analysis of a randomised
controlled trial. Lancet Respir Med. 6:691–698. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sinha P, Delucchi KL, Thompson BT, McAuley
DF and Matthay MA: Latent class analysis of ARDS subphenotypes: A
secondary analysis of the statins for acutely injured lungs from
sepsis (SAILS) study. Intensive Care Med. 44:1859–1869. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Wilde AH, Jochmans D, Posthuma CC,
Zevenhoven-Dobbe JC, van Nieuwkoop S, Bestebroer TM, van den Hoogen
BG, Neyts J and Snijder EJ: Screening of an FDA-approved compound
library identifies four small-molecule inhibitors of Middle East
respiratory syndrome coronavirus replication in cell culture.
Antimicrob Agents Chemother. 58:4875–4884. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cascella M, Rajnik M, Cuomo A, Dulebohn SC
and Di Napoli R: Features, evaluation and treatment coronavirus
(COVID-19). StatPearls [Internet] Treasure Island (FL): StatPearls
Publishing; 2020 Jan. PubMed/NCBIhttps://www.ncbi.nlm.nih.gov/books/NBK554776.
|
|
19
|
Neagu M, Bostan M and Constantin C:
Protein microarray technology: Assisting personalized medicine in
oncology (Review). World Acad Sci J. 1:113–124. 2019.
|
|
20
|
Levitt JE and Rogers AJ: Proteomic study
of acute respiratory distress syndrome: Current knowledge and
implications for drug development. Expert Rev Proteomics.
13:457–469. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meyer NJ, Reilly JP, Anderson BJ,
Palakshappa JA, Jones TK, Dunn TG, Shashaty MGS, Feng R, Christie
JD and Opal SM: Mortality benefit of recombinant human
interleukin-1 receptor antagonist for sepsis varies by initial
interleukin-1 receptor antagonist plasma concentration. Crit Care
Med. 46:21–28. 2018. View Article : Google Scholar
|
|
22
|
Brandes M, Klauschen F, Kuchen S and
Germain RN: A systems analysis identifies a feed forward
inflammatory circuit leading to lethal influenza infection. Cell.
154:197–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bowen JR, Ferris MT and Suthar MS: Systems
biology: A tool for charting the antiviral landscape. Virus Res.
218:2–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kindler E, Thiel V and Weber F:
Interaction of SARS and MERS coronaviruses with the antiviral
interferon response. Adv Virus Res. 96:219–243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Channappanavar R, Fehr AR, Vijay R, Mack
M, Zhao J, Meyerholz DK and Perlman S: Dysregulated type I
interferon and inflammatory monocyte-macrophage responses cause
lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe.
19:181–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baughman RP, Gunther KL, Rashkin MC,
Keeton DA and Pattishall EN: Changes in the inflammatory response
of the lung during acute respiratory distress syndrome: Prognostic
indicators. Am J Respir Crit Care Med. 154:76–81. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kast RE: Dapsone as treatment adjunct in
ARDS. Exp Lung Res. 46:157–161. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coleman MD, Rhodes LE, Scott AK, Verbov
JL, Friedmann PS, Breckenridge AM and Park BK: The use of
cimetidine to reduce dapsone-dependent methaemoglobinaemia in
dermatitis herpetiformis patients. Br J Clin Pharmacol. 34:244–249.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo
IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W and Ahmed N: Novel
coronavirus 2019-nCoV: Prevalence, biological and clinical
characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med
Pharmacol Sci. 24:2012–2019. 2020.PubMed/NCBI
|
|
30
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS-CoV-2 infection: Mechanistic insights into current
COVID-19 therapies (Review). Int J Mol Med. 46:467–488. 2020.
|
|
31
|
Tsatsakis A, Petrakis D, Nikolouzakis TK,
Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis
C, Aschner M, et al: COVID-19, an opportunity to reevaluate the
correlation between long-term effects of anthropogenic pollutants
on viral epidemic/pandemic events and prevalence. Food Chem
Toxicol. 141:1114182020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu
P, Meng J, Zhu Z, Zhang Z, Wang J, et al: Genome composition and
divergence of the novel coronavirus (2019-nCoV) originating in
China. Cell Host Microbe. 27:325–328. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sah R, Rodriguez-Morales AJ, Jha R, Chu
DKW, Gu H, Peiris M, Bastola A, Lal BK, Ojha HC, Rabaan AA, et al:
Complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2)
strain isolated in Nepal. Microbiol Resour Announc. 9:92020.
View Article : Google Scholar
|
|
35
|
Cui J, Li F and Shi ZL: Origin and
evolution of pathogenic coronaviruses. Nat Rev Microbiol.
17:181–192. 2019. View Article : Google Scholar
|
|
36
|
Xu J, Zhao S, Teng T, Abdalla AE, Zhu W,
Xie L, Wang Y and Guo X: Systematic comparison of two
animal-to-human transmitted human coronaviruses: SARS-CoV-2 and
SARS-CoV. Viruses. 12:122020. View Article : Google Scholar
|
|
37
|
Liu W and Li H: COVID-19: Attacks the
1-beta chain of hemoglobin and captures the porphyrin to inhibit
human heme metabolism. ChemRxiv. 2020, Preprint. https://doi.org/10.26434/chemrxiv.11938173.v8.
|
|
38
|
Yang Q, Bai S-Y, Li L-F, Li S, Zhang Y,
Munir M and Qiu H-J: Human hemoglobin subunit beta functions as a
pleiotropic regulator of RIG-I/MDA5-mediated antiviral innate
immune responses. J Virol. 93:932019. View Article : Google Scholar
|
|
39
|
Li T, Lu H and Zhang W: Clinical
observation and management of COVID-19 patients. Emerg Microbes
Infect. 9:687–690. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wan Y, Shang J, Graham R, Baric RS and Li
F: Receptor recognition by the novel coronavirus from Wuhan: An
analysis based on decade-long structural studies of SARS
coronavirus. J Virol. 94:942020. View Article : Google Scholar
|
|
41
|
Xie M and Chen Q: Insight into 2019 novel
coronavirus - An updated interim review and lessons from SARS-CoV
and MERS-CoV. Int J Infect Dis. 94:119–124. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hwang SS, Lim J, Yu Z, Kong P, Sefik E, Xu
H, Harman CCD, Kim LK, Lee GR, Li HB and Flavell RA: mRNA
destabilization by BTG1 and BTG2 maintains T cell quiescence.
Science. 367:1255–1260. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Coutard B, Valle C, de Lamballerie X,
Canard B, Seidah NG and Decroly E: The spike glycoprotein of the
new coronavirus 2019-nCoV contains a furin-like cleavage site
absent in CoV of the same clade. Antiviral Res. 176:1047422020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kawase M, Shirato K, van der Hoek L,
Taguchi F and Matsuyama S: Simultaneous treatment of human
bronchial epithelial cells with serine and cysteine protease
inhibitors prevents severe acute respiratory syndrome coronavirus
entry. J Virol. 86:6537–6545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S,
Qi F, Bao L, Du L, Liu S, et al: Inhibition of SARS-CoV-2
(previously 2019-nCoV) infection by a highly potent pan-coronavirus
fusion inhibitor targeting its spike protein that harbors a high
capacity to mediate membrane fusion. Cell Res. 30:343–355. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Millet JK and Whittaker GR: Physiological
and molecular triggers for SARS-CoV membrane fusion and entry into
host cells. Virology. 517:3–8. 2018. View Article : Google Scholar
|
|
48
|
Totura AL and Bavari S: Broad-spectrum
coronavirus antiviral drug discovery. Expert Opin Drug Discov.
14:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Amatngalim GD and Hiemstra PS: Airway
epithelial cell function and respiratory host defense in chronic
obstructive pulmonary disease. Chin Med J (Engl). 131:1099–1107.
2018. View Article : Google Scholar
|
|
50
|
Chiang JJ, Davis ME and Gack MU:
Regulation of RIG-I-like receptor signaling by host and viral
proteins. Cytokine Growth Factor Rev. 25:491–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schneider WM, Chevillotte MD and Rice CM:
Interferonstimulated genes: A complex web of host defenses. Annu
Rev Immunol. 32:513–545. 2014. View Article : Google Scholar
|
|
52
|
Takeuchi O and Akira S: Pattern
recognition receptors and inflammation. Cell. 140:805–820. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dixit E, Boulant S, Zhang Y, Lee AS,
Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, et
al: Peroxisomes are signaling platforms for antiviral innate
immunity. Cell. 141:668–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kindler E, Gil-Cruz C, Spanier J, Li Y,
Wilhelm J, Rabouw HH, Züst R, Hwang M, V'kovski P, Stalder H, et
al: Early endonuclease-mediated evasion of RNA sensing ensures
efficient coronavirus replication. PLoS Pathog. 13:e10061952017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cao W, Bao C, Padalko E and Lowenstein CJ:
Acetylation of mitogen-activated protein kinase phosphatase-1
inhibits Toll-like receptor signaling. J Exp Med. 205:1491–1503.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhou Y, He C, Wang L and Ge B:
Post-translational regulation of antiviral innate signaling. Eur J
Immunol. 47:1414–1426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Quicke KM, Diamond MS and Suthar MS:
Negative regulators of the RIG-I-like receptor signaling pathway.
Eur J Immunol. 47:615–628. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Vincent MJ, Bergeron E, Benjannet S,
Erickson BR, Rollin PE, Ksiazek TG, Seidah NG and Nichol ST:
Chloroquine is a potent inhibitor of SARS coronavirus infection and
spread. Virol J. 2:692005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Samarth S and McGregor K: Energetics based
modeling of hydroxychloroquine and azithromycin binding to the
SARS-CoV-2 spike (S)protein - ACE2 complex. ChemRxiv. 2020,
Preprint. https://doi.org/10.26434/chemrxiv.12015792.v2.
|
|
60
|
Arya R, Das A, Prashar V and Kumar M:
Potential inhibitors against papain-like protease of novel
coronavirus (SARS-CoV-2) from FDA approved drugs. ChemrxivOrg. 1–8.
2020. View Article : Google Scholar
|
|
61
|
Dyall J, Gross R, Kindrachuk J, Johnson
RF, Olinger GG Jr, Hensley LE, Frieman MB and Jahrling PB: Middle
East respiratory syndrome and severe acute respiratory syndrome:
Current therapeutic options and potential targets for novel
therapies. Drugs. 77:1935–1966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Choudhary S, Malik YS and Tomar S:
Identification of SARS-CoV-2 cell entry inhibitors by drug
repurposing using in silico structure-based virtual screening
approach. ChemRxiv. 2020. View Article : Google Scholar
|
|
63
|
Farag A, Wang P, Boys IN, Eitson J, Ohlson
MB, Fan W, McDougal MB, Ahmed M and Schoggins JW: Identification of
atovaquone, quabain and mebendazole as FDA approved drugs
Tar-geting SARS-CoV-2 (Version 4). 2020, ChemRxiv. Preprint
https://doi.org/10.26434/chemrxiv.12003930.v4.
|
|
64
|
Navan C: Possible Drug Candidates for
COVID-19. ChemRxiv. 2020, Preprint. https://doi.org/10.26434/chemrxiv.11985231.v1.
|
|
65
|
Bag A and Bag A: Treatment of COVID-19
patients: Justicia adhatoda leaves extract is a strong remedy for
COVID-19- Case report analysis and docking based study. ChemRxiv.
2020, Preprint. https://doi.org/10.26434/chemrxiv.12038604.v1.
|
|
66
|
Coleman CM, Sisk JM, Mingo RM, Nelson EA,
White JM and Frieman MB: Abelson kinase inhibitors are potent
inhibitors of severe acute respiratory syndrome coronavirus and
Middle East respiratory syndrome coronavirus fusion. J Virol.
90:8924–8933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sisk JM, Frieman MB and Machamer CE:
Coronavirus S protein-induced fusion is blocked prior to hemifusion
by Abl kinase inhibitors. J Gen Virol. 99:619–630. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Salim B and Noureddine M: Identification
of compounds from Nigella sativa as new potential inhibitors of
2019 novel corona virus (Covid-19): Molecular docking study.
ChemRxiv. 2020, Preprint. https://doi.org/10.26434/chemrxiv.12055716.v1.
|
|
69
|
Pendyala B and Patras A: In silico
screening of food bioactive compounds to predict potential
inhibitors of COVID-19 main protease (Mpro) and RNA-dependent RNA
polymerase (RdRp). ChemRxiv Preprint. https://doi.org/10.26434/chemrxiv.12051927.v2.
|
|
70
|
Mohammadi N: Inhibitory effect of eight
secondary metabolites from conventional medicinal plants on
COVID-19 virus protease by molecular docking analysis. ChemRxiv.
2020, Preprint. https://doi.org/10.26434/chemrxiv.11987475.v1.
|
|
71
|
Bosch BJ, Martina BEE, Van Der Zee R,
Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus
AD and Rottier PJ: Severe acute respiratory syndrome coronavirus
(SARS-CoV) infection inhibition using spike protein heptad
repeat-derived peptides. Proc Natl Acad Sci USA. 101:8455–8460.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yang Z-Y, Huang Y, Ganesh L, Leung K, Kong
WP, Schwartz O, Subbarao K and Nabel GJ: pH-dependent entry of
severe acute respiratory syndrome coronavirus is mediated by the
spike glycoprotein and enhanced by dendritic cell transfer through
DC-SIGN. J Virol. 78:5642–5650. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhao J, Wohlford-Lenane C, Zhao J, Fleming
E, Lane TE, McCray PB Jr and Perlman S: Intranasal treatment with
poly(I•C) protects aged mice from lethal respiratory virus
infections. J Virol. 86:11416–11424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mian MF, Ahmed AN, Rad M, Babaian A,
Bowdish D and Ashkar AA: Length of dsRNA (poly I:C) drives distinct
innate immune responses, depending on the cell type. J Leukoc Biol.
94:1025–1036. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Cameron A, Appel J, Houghten RA and
Lindberg I: Polyarginines are potent furin inhibitors. J Biol Chem.
275:36741–36749. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Channappanavar R, Lu L, Xia S, Du L,
Meyerholz DK, Perlman S and Jiang S: Protective effect of
intranasal regimens containing peptidic Middle East respiratory
syndrome coronavirus fusion inhibitor against MERS-CoV infection. -
Abstract - Europe PMC. https://europepmc.org/article/med/26164863.
|
|
77
|
Zhou H, Zhao J and Perlman S: Autocrine
interferon priming in macrophages but not dendritic cells results
in enhanced cytokine and chemokine production after coronavirus
infection. MBio. 1:12010. View Article : Google Scholar
|
|
78
|
Iwasaki A and Medzhitov R: Regulation of
adaptive immunity by the innate immune system. Science.
327:291–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Sainz B Jr, Mossel EC, Peters CJ and Garry
RF: Interferon-beta and interferon-gamma synergistically inhibit
the replication of severe acute respiratory syndrome-associated
coronavirus (SARS-CoV). Virology. 329:11–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Der SD, Zhou A, Williams BRG and Silverman
RH: Identification of genes differentially regulated by interferon
α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci USA.
95:15623–15628. 1998. View Article : Google Scholar
|
|
81
|
Bauman DR, Bitmansour AD, McDonald JG,
Thompson BM, Liang G and Russell DW: 25-Hydroxycholesterol secreted
by macrophages in response to Toll-like receptor activation
suppresses immunoglobulin A production. Proc Natl Acad Sci USA.
106:16764–16769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Mantovani A, Biswas SK, Galdiero MR, Sica
A and Locati M: Macrophage plasticity and polarization in tissue
repair and remodelling. J Pathol. 229:176–185. 2013. View Article : Google Scholar
|
|
83
|
Gralinski LE and Baric RS: Molecular
pathology of emerging coronavirus infections. J Pathol.
235:185–195. 2015. View Article : Google Scholar
|
|
84
|
de Wilde AH, Wannee KF, Scholte FEM,
Goeman JJ, Ten Dijke P, Snijder EJ, Kikkert M and van Hemert MJ: A
kinome-wide small interfering RNA screen identifies proviral and
antiviral host factors in severe acute respiratory syndrome
coronavirus replication, including double-stranded RNA-activated
protein kinase and early secretory pathway proteins. J Virol.
89:8318–8333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Newton DA, Rao KMK, Dluhy RA and Baatz JE:
Hemoglobin is expressed by alveolar epithelial cells. J Biol Chem.
281:5668–5676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Aldajani WA, Salazar F, Sewell HF, Knox A
and Ghaemmaghami AM: Expression and regulation of immunemodulatory
enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial
cells and its effect on T cell activation. Oncotarget.
7:57606–57617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Mondanelli G, Bianchi R, Pallotta MT,
Orabona C, Albini E, Iacono A, Belladonna ML, Vacca C, Fallarino F,
Macchiarulo A, et al: A relay pathway between arginine and
tryptophan metabolism confers immunosuppressive properties on
dendritic cells. Immunity. 46:233–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Nordgren M and Fransen M: Peroxisomal
metabolism and oxidative stress. Biochimie. 98:56–62. 2014.
View Article : Google Scholar
|
|
89
|
Titorenko VI and Terlecky SR: Peroxisome
metabolism and cellular aging. Traffic. 12:252–259. 2011.
View Article : Google Scholar :
|
|
90
|
Xu Z, Lodge R, Power C, Cohen EA and
Hobman TC: The HIV-1 accessory protein vpu downregulates peroxisome
biogenesis. MBio. 11:112020. View Article : Google Scholar
|
|
91
|
Zheng C and Su C: Herpes simplex virus 1
infection dampens the immediate early antiviral innate immunity
signaling from peroxisomes by tegument protein VP16. Virol J.
14:352017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ferreira AR, Marques M and Ribeiro D:
Peroxisomes and innate immunity: Antiviral response and beyond. Int
J Mol Sci. 20:202019. View Article : Google Scholar
|
|
93
|
Skalny AV, Rink L, Ajsuvakova OP, Aschner
M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos
DA, Aaseth J, et al: Zinc and respiratory tract infections:
Perspectives for COVID-19 (Review). Int J Mol Med. 46:17–26.
2020.
|
|
94
|
Gastaminza P, Whitten-Bauer C and Chisari
FV: Unbiased probing of the entire hepatitis C virus life cycle
identifies clinical compounds that target multiple aspects of the
infection. Proc Natl Acad Sci USA. 107:291–296. 2010. View Article : Google Scholar
|
|
95
|
Simmons G, Gosalia DN, Rennekamp AJ,
Reeves JD, Diamond SL and Bates P: Inhibitors of cathepsin L
prevent severe acute respiratory syndrome coronavirus entry. Proc
Natl Acad Sci USA. 102:11876–11881. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Blanchard E, Belouzard S, Goueslain L,
Wakita T, Dubuisson J, Wychowski C and Rouillé Y: Hepatitis C virus
entry depends on clathrin-mediated endocytosis. J Virol.
80:6964–6972. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Trevani AS, Andonegui G, Giordano M, López
DH, Gamberale R, Minucci F and Geffner JR: Extracellular
acidification induces human neutrophil activation. J Immunol.
162:4849–4857. 1999.PubMed/NCBI
|
|
98
|
Rotstein OD, Fiegel VD, Simmons RL and
Knighton DR: The deleterious effect of reduced pH and hypoxia on
neutrophil migration in vitro. J Surg Res. 45:298–303. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lardner A: The effects of extracellular pH
on immune function. J Leukoc Biol. 69:522–530. 2001.PubMed/NCBI
|
|
100
|
Simchowitz L: Intracellular pH modulates
the generation of superoxide radicals by human neutrophils. J Clin
Invest. 76:1079–1089. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Severin T, Müller B, Giese G, Uhl B, Wolf
B, Hauschildt S and Kreutz W: pH-dependent LAK cell cytotoxicity.
Tumour Biol. 15:304–310. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kellum JA, Song M and Li J: Science
review: extracellular acidosis and the immune response: clinical
and physiologic implications. Crit Care. 8:331–336. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Hamdullah KS, Tanzila A, Zainab Sher M,
Iqra A and Mohtasheemul H: pH dependent differential binding
behavior of protease inhibitor molecular drugs for SARS-COV-2.
ChemRxiv. 2020, Preprint. https://doi.org/10.26434/chemrxiv.12009018.v1.
|
|
104
|
Leneva IA, Russell RJ, Boriskin YS and Hay
AJ: Characteristics of arbidol-resistant mutants of influenza
virus: Implications for the mechanism of anti-influenza action of
arbidol. Antiviral Res. 81:132–140. 2009. View Article : Google Scholar
|
|
105
|
Bhargava M, Becker TL, Viken KJ, Jagtap
PD, Dey S, Steinbach MS, Wu B, Kumar V, Bitterman PB, Ingbar DH, et
al: Proteomic profiles in acute respiratory distress syndrome
differentiates survivors from non-survivors. PLoS One.
9:e1097132014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Shortt K, Chaudhary S, Grigoryev D, Heruth
DP, Venkitachalam L, Zhang LQ and Ye SQ: Identification of novel
single nucleotide polymorphisms associated with acute respiratory
distress syndrome by exome-seq. PLoS One. 9:e1119532014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Tejera P, Meyer NJ, Chen F, Feng R, Zhao
Y, O′Mahony DS, Li L, Sheu CC, Zhai R, Wang Z, et al: Distinct and
replicable genetic risk factors for acute respiratory distress
syndrome of pulmonary or extrapulmonary origin. J Med Genet.
49:671–680. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Lynn H, Sun X, Casanova N, Gonzales-Garay
M, Bime C and Garcia JGN: Genomic and genetic approaches to
deciphering acute respiratory distress syndrome risk and mortality.
Antioxid Redox Signal. 31:1027–1052. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Marshall RP, Webb S, Bellingan GJ,
Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR and
Laurent GJ: Angiotensin converting enzyme insertion/deletion
polymorphism is associated with susceptibility and outcome in acute
respiratory distress syndrome. Am J Respir Crit Care Med.
166:646–650. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Itoyama S, Keicho N, Quy T, Phi NC, Long
HT, Ha LD, Ban VV, Ohashi J, Hijikata M, Matsushita I, et al: ACE1
polymorphism and progression of SARS. Biochem Biophys Res Commun.
323:1124–1129. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Chan KCA, Tang NLS, Hui DSC, Chung GT, Wu
AK, Chim SS, Chiu RW, Lee N, Choi KW, Sung YM, et al: Absence of
association between angiotensin converting enzyme polymorphism and
development of adult respiratory distress syndrome in patients with
severe acute respiratory syndrome: A case control study. BMC Infect
Dis. 5:262005. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Fourrier F, Chopin C, Wallaert B, Wattre
P, Mangalaboyi J, Durocher A, Dubois D and Wattel F:
Angiotensin-converting enzyme in human adult respiratory distress
syndrome. Chest. 83:593–597. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan
B, Yang P, Sarao R, Wada T, Leong-Poi H, et al:
Angiotensin-converting enzyme 2 protects from severe acute lung
failure. Nature. 436:112–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Arndt PG, Young SK, Poch KR, Nick JA, Falk
S, Schrier RW and Worthen GS: Systemic inhibition of the
angiotensin-converting enzyme limits lipopolysaccharide-induced
lung neutrophil recruitment through both bradykinin and angiotensin
II-regulated pathways. J Immunol. 177:7233–7241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Kim J, Choi SM, Lee J, Park YS, Lee CH,
Yim JJ, Yoo CG, Kim YW, Han SK and Lee SM: Effect of
renin-angiotensin system blockage in patients with acute
respiratory distress syndrome: A retrospective case control study.
Korean J Crit Care Med. 32:154–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Wevers BA and van der Hoek L:
Renin-angiotensin system in human coronavirus pathogenesis. Future
Virol. 5:145–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chappell MC: Angiotensin-(17) and the
regulation of anti-fibrotic signaling pathways. J Cell Signal.
2:1342017. View Article : Google Scholar
|
|
118
|
El-Hashim AZ, Renno WM, Raghupathy R,
Abduo HT, Akhtar S and Benter IF: Angiotensin-(17) inhibits
allergic inflammation, via the MAS1 receptor, through suppression
of ERK1/2- and NF-κB-dependent pathways. Br J Pharmacol.
166:1964–1976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Manolis AJ, Marketou ME, Gavras I and
Gavras H: Cardioprotective properties of bradykinin: Role of the
B(2) receptor. Hypertens Res. 33:772–777. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Adam A, Cugno M, Molinaro G, Perez M,
Lepage Y and Agostoni A: Aminopeptidase P in individuals with a
history of angio-oedema on ACE inhibitors. Lancet. 359:2088–2089.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Yeager CL, Ashmun RA, Williams RK,
Cardellichio CB, Shapiro LH, Look AT and Holmes KV: Human
aminopeptidase N is a receptor for human coronavirus 229E. Nature.
357:420–422. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Morris SM Jr: Arginine: Master and
commander in innate immune responses. Sci Signal. 3:pe272010.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Keyaerts E, Vijgen L, Chen L, Maes P,
Hedenstierna G and Van Ranst M: Inhibition of SARS-coronavirus
infection in vitro by S-nitroso-N- acetylpenicillamine, a nitric
oxide donor compound. International Journal of Infectious Diseases
Int J Infect Dis. 8:223–226. 2004. View Article : Google Scholar
|
|
124
|
Akerström S, Mousavi-Jazi M, Klingström J,
Leijon M, Lundkvist A and Mirazimi A: Nitric oxide inhibits the
replication cycle of severe acute respiratory syndrome coronavirus.
J Virol. 79:1966–1969. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Cinatl J, Morgenstern B, Bauer G, Chandra
P, Rabenau H and Doerr HW: Treatment of SARS with human
interferons. Lancet. 362:293–294. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Karupiah G, Xie QW, Buller RML, Nathan C,
Duarte C and MacMicking JD: Inhibition of viral replication by
interferon-γ-induced nitric oxide synthase. Science. 261:1445–1448.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Burrack KS and Morrison TE: The role of
myeloid cell activation and arginine metabolism in the pathogenesis
of virus-induced diseases. Front Immunol. 5:4282014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Munder M, Schneider H, Luckner C, Giese T,
Langhans CD, Fuentes JM, Kropf P, Mueller I, Kolb A, Modolell M, et
al: Suppression of T-cell functions by human granulocyte arginase.
Blood. 108:1627–1634. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Racké K and Warnken M: L-Arginine
metabolic pathways. The Open Nitric Oxide Journal. 2:pp. 9–19.
2010, https://benthamopen.com/contents/pdf/TONOJ/TONOJ-2-9.pdf.
View Article : Google Scholar
|
|
130
|
Gournas C, Papageorgiou I and Diallinas G:
The nucleobaseascorbate transporter (NAT) family: Genomics,
evolution, structure-function relationships and physiological role.
Mol Biosyst. 4:404–416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Carr AC and Maggini S: Vitamin C and
immune function. Nutrients. 9:92017. View Article : Google Scholar
|
|
132
|
García-Bailo B, Roke K, Mutch DM,
El-Sohemy A and Badawi A: Association between circulating ascorbic
acid, α-tocopherol, 25-hydroxyvitamin D, and plasma cytokine
concentrations in young adults: A cross-sectional study. Nutr Metab
(Lond). 9:1022012. View Article : Google Scholar
|
|
133
|
Wu G and Morris SM Jr: Arginine
metabolism: Nitric oxide and beyond. Biochem J. 336:1–17. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Scheit K and Bauer G: Synergistic effects
between catalase inhibitors and modulators of nitric oxide
metabolism on tumor cell apoptosis. Anticancer Res. 34:5337–5350.
2014.PubMed/NCBI
|
|
135
|
Thomas SR, Mohr D and Stocker R: Nitric
oxide inhibits indoleamine 2,3-dioxygenase activity in
interferon-gamma primed mononuclear phagocytes. J Biol Chem.
269:14457–14464. 1994.PubMed/NCBI
|
|
136
|
Shi HP, Efron DT, Most D, Tantry US and
Barbul A: Supplemental dietary arginine enhances wound healing in
normal but not inducible nitric oxide synthase knockout mice.
Surgery. 128:374–378. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Rodriguez PC, Quiceno DG and Ochoa AC:
L-arginine availability regulates T-lymphocyte cell-cycle
progression. Blood. 109:1568–1573. 2007. View Article : Google Scholar
|
|
138
|
Ochoa JB, Strange J, Kearney P, Gellin G,
Endean E and Fitzpatrick E: Effects of L-arginine on the
proliferation of T lymphocyte subpopulations. JPEN J Parenter
Enteral Nutr. 25:23–29. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
de Jonge WJ, Kwikkers KL, te Velde AA, van
Deventer SJ, Nolte MA, Mebius RE, Ruijter JM, Lamers MC and Lamers
WH: Arginine deficiency affects early B cell maturation and
lymphoid organ development in transgenic mice. J Clin Invest.
110:1539–1548. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Manning J, Mitchell B, Appadurai DA,
Shakya A, Pierce LJ, Wang H, Nganga V, Swanson PC, May JM, Tantin
D, et al: Vitamin C promotes maturation of T-cells. Antioxid Redox
Signal. 19:2054–2067. 2013. View Article : Google Scholar :
|
|
141
|
Dahl H and Degré M: The effect of
ascorbic acid on production of human interferon and the antiviral
activity in vitro. Acta Pathol Microbiol Scand B. 84B:B280–B284.
1976.
|
|
142
|
Huijskens MJAJ, Walczak M, Sarkar S,
Atrafi F, Senden-Gijsbers BL, Tilanus MG, Bos GM, Wieten L and
Germeraad WT: Ascorbic acid promotes proliferation of natural
killer cell populations in culture systems applicable for natural
killer cell therapy. Cytotherapy. 17:613–620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Anderson R: Assessment of oral ascorbate
in three children with chronic granulomatous disease and defective
neutrophil motility over a 2-year period. Clin Exp Immunol.
43:180–188. 1981.PubMed/NCBI
|
|
144
|
Patrone F, Dallegri F, Bonvini E,
Minervini F and Sacchetti C: Effects of ascorbic acid on neutrophil
function. Studies on normal and chronic granulomatous disease
neutrophils. Acta Vitaminol Enzymol. 4:163–168. 1982.PubMed/NCBI
|
|
145
|
Moraes MP, de Los Santos T, Koster M,
Turecek T, Wang H, Andreyev VG and Grubman MJ: Enhanced antiviral
activity against foot-and-mouth disease virus by a combination of
type I and II porcine interferons. J Virol. 81:7124–7135. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Peng T, Zhu J, Hwangbo Y, Corey L and
Bumgarner RE: Independent and cooperative antiviral actions of beta
interferon and gamma interferon against herpes simplex virus
replication in primary human fibroblasts. J Virol. 82:1934–1945.
2008. View Article : Google Scholar :
|
|
147
|
Bartee E, Mohamed MR, Lopez MC, Baker HV
and McFadden G: The addition of tumor necrosis factor plus beta
interferon induces a novel synergistic antiviral state against
poxviruses in primary human fibroblasts. J Virol. 83:498–511. 2009.
View Article : Google Scholar :
|
|
148
|
Page C, Goicochea L, Matthews K, Zhang Y,
Klover P, Holtzman MJ, Hennighausen L and Frieman M: Induction of
alternatively activated macrophages enhances pathogenesis during
severe acute respiratory syndrome coronavirus infection. J Virol.
86:13334–13349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Block G, Jensen CD, Dalvi TB, Norkus EP,
Hudes M, Crawford PB, Holland N, Fung EB, Schumacher L and Harmatz
P: Vitamin C treatment reduces elevated C-reactive protein. Free
Radic Biol Med. 46:70–77. 2009. View Article : Google Scholar :
|
|
150
|
Kim WY, Jung JW, Choi JC, Shin JW and Kim
JY: Subphenotypes in patients with septic shock receiving vitamin
C, hydrocortisone, and thiamine: A retrospective cohort analysis.
Nutrients. 11:112019. View Article : Google Scholar
|
|
151
|
Grahame Hardie D: Regulation of
AMP-activated protein kinase by natural and synthetic activators.
Acta Pharm Sin B. 6:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Pagé EL, Chan DA, Giaccia AJ, Levine M
and Richard DE: Hypoxia-inducible factor-1α stabilization in
nonhypoxic conditions: Role of oxidation and intracellular
ascorbate depletion. Mol Biol Cell. 19:86–94. 2008. View Article : Google Scholar
|
|
153
|
Witte MB and Barbul A: Arginine physiology
and its implication for wound healing. Wound Repair Regen.
11:419–423. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Padayatty SJ, Sun H, Wang Y, Riordan HD,
Hewitt SM, Katz A, Wesley RA and Levine M: Vitamin C
pharmacokinetics: Implications for oral and intravenous use. Ann
Intern Med. 140:533–537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Stancioiu F: Antiviral activity of
L-arginine and extended-release Vitamin C. AASCIT J Health.
3:13–16. 2016.
|
|
156
|
Bertolini G, Iapichino G, Radrizzani D,
Facchini R, Simini B, Bruzzone P, Zanforlin G and Tognoni G: Early
enteral immunonutrition in patients with severe sepsis: Results of
an interim analysis of a randomized multicentre clinical trial.
Intensive Care Med. 29:834–840. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Heyland DK, Novak F, Drover JW, Jain M, Su
X and Suchner U: Should immunonutrition become routine in
critically ill patients? A systematic review of the evidence. JAMA.
286:944–953. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Rosenthal MD, Rosenthal C, Patel J, Jordan
J and Go K: Arginine in the critically ill: Can we finally push
past the controversy? Int J Crit Care Emerg Med. 2:0172016.
View Article : Google Scholar
|
|
159
|
Galbán C, Montejo JC, Mesejo A, Marco P,
Celaya S, Sánchez-Segura JM, Farré M and Bryg DJ: An
immune-enhancing enteral diet reduces mortality rate and episodes
of bacteremia in septic intensive care unit patients. Crit Care
Med. 28:643–648. 2000. View Article : Google Scholar
|
|
160
|
Luiking YC, Poeze M and Deutz NE: Arginine
infusion in patients with septic shock increases nitric oxide
production without haemodynamic instability. Clin Sci (Lond).
128:57–67. 2015. View Article : Google Scholar
|
|
161
|
Gough MS, Morgan MAM, Mack CM, Darling DC,
Frasier LM, Doolin KP, Apostolakos MJ, Stewart JC, Graves BT,
Arning E, et al: The ratio of arginine to dimethylarginines is
reduced and predicts outcomes in patients with severe sepsis. Crit
Care Med. 39:1351–1358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Visser M, Davids M, Verberne HJ, Kok WE,
Tepaske R, Cocchieri R, Kemper EM, Teerlink T, Jonker MA, Wisselink
W, et al: Nutrition before, during, and after surgery increases the
arginine:asymmetric dimethylarginine ratio and relates to improved
myocardial glucose metabolism: a randomized controlled trial. Am J
Clin Nutr. 99:1440–1449. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Visser M, Vermeulen MAR, Richir MC,
Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van
Leeuwen PA and Oudemans-van Straaten HM: Imbalance of arginine and
asymmetric dimethylarginine is associated with markers of
circulatory failure, organ failure and mortality in shock patients.
Br J Nutr. 107:1458–1465. 2012. View Article : Google Scholar
|
|
164
|
Arora TK, Malhotra AK, Ivatury R and
Mangino MJ: L-arginine infusion during resuscitation for
hemorrhagic shock: Impact and mechanism. J Trauma Acute Care Surg.
72:397–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wu F, Wilson JX and Tyml K: Ascorbate
protects against impaired arteriolar constriction in sepsis by
inhibiting inducible nitric oxide synthase expression. Free Radic
Biol Med. 37:1282–1289. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Wang Y, Lin H, Lin BW and Lin JD: Effects
of different ascorbic acid doses on the mortality of critically ill
patients: a meta-analysis. Ann Intensive Care. 9:582019. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Fowler AA III, Truwit JD, Hite RD, Morris
PE, DeWilde C, Priday A, Fisher B, Thacker LR II, Natarajan R,
Brophy DF, et al: Effect of vitamin C infusion on organ failure and
biomarkers of inflammation and vascular injury in patients with
sepsis and severe acute respiratory failure: The CITRIS-ALI
Randomized Clinical Trial. JAMA. 322:1261–1270. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.
|
|
169
|
Chan MHM, Wong VWS, Wong CK, Chan PK, Chu
CM, Hui DS, Suen MW, Sung JJ, Chung SS and Lam CW: Serum LD1
isoenzyme and blood lymphocyte subsets as prognostic indicators for
severe acute respiratory syndrome. J Intern Med. 255:512–518. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Hicks CW, Wang D, Daya NR, Windham BG,
Ballantyne CM, Matsushita K and Selvin E: Associations of cardiac,
kidney, and diabetes biomarkers with peripheral neuropathy among
older adults in the atherosclerosis risk in communities (ARIC)
study. Clin Chem. 66:686–696. 2020. View Article : Google Scholar : PubMed/NCBI
|
